Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

LMOD+: A Comprehensive Multimodal Dataset and Benchmark for Developing and Evaluating Multimodal Large Language Models in Ophthalmology.

ACM transactions on computing for healthcare·2026
Same author

DeepER-Med: Advancing Deep Evidence-Based Research in Medicine Through Agentic AI.

ArXiv·2026
Same author

Avacincaptad Pegol Slows Progressive Ellipsoid Zone Degradation/Loss in Eyes With Geographic Atrophy.

Ophthalmology·2026
Same author

Retinal biomarkers for visual prognosis in pituitary surgery: a narrative review.

Pituitary·2026
Same author

Multi-omic analysis of deep learning-derived phenotypes links ophthalmic imaging to cardiovascular and neurological traits.

Nature cardiovascular research·2026
Same author

Age-related macular degeneration severity and risk of Alzheimer's disease in older adults in a prospective, community-based cohort study.

Alzheimer's & dementia (Amsterdam, Netherlands)·2026

Related Experiment Video

Updated: Jul 3, 2026

Virtual Agent for Real-Time Motivational Interviewing by Integrating Adaptive Nonverbal Behavior and Language Models
07:14

Virtual Agent for Real-Time Motivational Interviewing by Integrating Adaptive Nonverbal Behavior and Language Models

Published on: December 23, 2025

Toward Multimodal Conversational AI for Age-Related Macular Degeneration.

Ran Gu1, Benjamin Hou1, Mélanie Hébert2

  • 1Division of Intramural Research, National Library of Medicine, National Institutes of Health, Bethesda, Maryland, USA.

Arxiv
|July 2, 2026
PubMed
Summary

OcularChat, a new AI model, accurately diagnoses age-related macular degeneration (AMD) using eye scans and provides explanations. This multimodal large language model (MLLM) enhances clinical decision-making and patient communication for retinal disease detection.

Keywords:
age-related macular degenerationcolor fundus photographsmultimodal large language modelsvisual question answering

Related Experiment Videos

Last Updated: Jul 3, 2026

Virtual Agent for Real-Time Motivational Interviewing by Integrating Adaptive Nonverbal Behavior and Language Models
07:14

Virtual Agent for Real-Time Motivational Interviewing by Integrating Adaptive Nonverbal Behavior and Language Models

Published on: December 23, 2025

Area of Science:

  • Ophthalmology
  • Artificial Intelligence
  • Medical Imaging

Background:

  • Deep learning models excel at retinal disease detection but lack clinical reasoning.
  • Multimodal large language models (MLLMs) integrate diagnostic predictions with dialogue for clinical support.
  • Existing systems offer static predictions, hindering interactive patient counseling and decision-making.

Purpose of the Study:

  • To develop and evaluate OcularChat, an MLLM fine-tuned for diagnosing age-related macular degeneration (AMD) using color fundus photographs (CFPs).
  • To assess OcularChat's ability to provide reasoned predictions, clinical explanations, and interactive dialogue for AMD classification.
  • To compare OcularChat's performance against existing MLLMs and ophthalmologist evaluations.

Main Methods:

  • Fine-tuning Qwen2.5-VL, an MLLM, using simulated patient-physician dialogues and CFPs.
  • Training OcularChat on 705,850 simulated dialogues and 46,167 CFPs for AMD feature identification and prediction.
  • Evaluating OcularChat's classification accuracy on AREDS and AREDS2 datasets and comparing its clinical grading scores with a baseline model and ophthalmologist assessments.

Main Results:

  • OcularChat achieved high accuracies for AMD diagnostic tasks on AREDS (0.954 for advanced AMD, 0.849 for pigmentary abnormalities, 0.678 for drusen size), outperforming existing MLLMs.
  • OcularChat demonstrated superior performance on all AREDS2 tasks.
  • Ophthalmologist evaluations showed OcularChat received higher mean scores than a baseline model for AMD severity classification and overall impression.

Conclusions:

  • OcularChat exhibits strong objective performance in AMD classification and provides accurate, interpretable diagnostic reasoning.
  • The MLLM enables clinically relevant explanations and interactive dialogue, enhancing patient counseling and decision-making.
  • MLLMs like OcularChat hold potential for accurate, interpretable, and clinically useful image-based diagnosis of retinal diseases such as AMD.